reconstituting lyophilized peptides · laboratory handling reference · research use only
How to reconstitute a lyophilized research peptide: the plain lab version.
Most research peptides ship as a lyophilized (freeze-dried) powder or a thin film at the bottom of a sealed vial, because a dry solid is far more stable than a solution. 'Reconstitution' just means dissolving that solid back into a liquid so it can be handled and measured. This page is a laboratory-handling reference for that step: what solvent is used, how to figure out the concentration, and how the reconstituted material is stored. The short version: a solvent (usually bacteriostatic water) is added slowly down the inside wall of the vial — not squirted directly onto the powder — and the vial is swirled, never shaken, until the solid dissolves; the concentration is simply the mass of peptide divided by the volume of solvent you added. Everything here is about the chemistry of dissolving and storing a research reagent. It is research-use-only and is NOT medical advice, NOT a dosing protocol, and NOT instructions for administering anything to a person or animal.
What 'bacteriostatic water' actually is
Bacteriostatic Water for Injection, USP is sterile, nonpyrogenic water that contains 0.9% (9 mg/mL) benzyl alcohol added as a bacteriostatic preservative, at pH 5.7 (Bacteriostatic Water for Injection, USP monograph; Pfizer/DailyMed labeling). That preservative is the whole point: it lets a multiple-dose vial be entered repeatedly without the solvent itself growing bacteria. By contrast, plain Sterile Water for Injection (SWFI) contains no preservative, so it is intended for single use. Some peptides that are sensitive to benzyl alcohol are instead dissolved in SWFI or acetic-acid solutions — the solvent is a per-compound choice, not one-size-fits-all.
How to store peptides →The concentration math (it is just division)
Concentration equals the mass of peptide divided by the volume of solvent you add: C (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). A 5 mg vial dissolved in 2 mL of bacteriostatic water is 2.5 mg/mL. Dissolve the same 5 mg vial in 1 mL and it is 5 mg/mL; in 5 mL it is 1 mg/mL. The amount of peptide in the vial never changes when you add solvent — only the concentration does. Choosing more solvent simply makes a more dilute, easier-to-measure solution. This is arithmetic for a laboratory reagent, not a dosing instruction.
Lot COA checklist →The mechanical step, done gently
Wipe the vial stopper with alcohol, draw the chosen volume of solvent, and let it run slowly down the inside glass wall so it drips onto the powder rather than blasting it. Then swirl or gently roll the vial — do not shake it. Peptides are chains that can physically denature and aggregate at an air-liquid interface, and vigorous shaking whips air into the solution and encourages exactly that. Give a stubborn film a few minutes at room temperature; most research peptides go fully into solution within minutes without any heat. If particulates remain after it has had time, that is information about the material, not something to force.
Browse lyophilized vials →Why the dry powder was stable and the solution is not
In the lyophilized solid, water activity and molecular mobility are minimal, so the chemical reactions that degrade peptides run very slowly — which is why vendors ship a freeze-dried powder in the first place. Once it is in water, those reactions restart. The peptide-stability literature catalogs them: hydrolysis of the backbone, deamidation, oxidation of susceptible residues (methionine, cysteine, tryptophan, histidine), and physical aggregation (Manning, Chou, Murphy, Payne & Katayama, 'Stability of Protein Pharmaceuticals: An Update,' Pharm Res 2010;27:544-575; building on Manning, Patel & Borchardt, Pharm Res 1989;6:903-918). That is the mechanistic reason reconstituted material has a much shorter usable life than the sealed dry vial.
Storage & shelf-life reference →Storing what you just reconstituted
Once in solution, the standard handling is refrigeration at roughly 2–8°C, protected from light, and avoiding repeated freeze-thaw cycles — each of which mechanically stresses and aggregates peptide chains. Where a solvent carries a preservative, laboratory beyond-use conventions matter: USP <797> assigns a 28-day beyond-use date to preserved multiple-dose vials, which is one reason a benzyl-alcohol-containing solvent is chosen for a vial that will be entered more than once. The sealed, unopened lyophilized vial is the most stable state; reconstitute the amount you will actually use rather than everything at once.
How to store peptides →Reconstitution only works if the powder is the right material
None of this handling matters if the vial does not contain what the label says. A truncated or mis-synthesized sequence can dissolve into a perfectly clear solution and still be the wrong peptide, so a clean-looking reconstitution proves nothing about identity. That is confirmed upstream, by mass spectrometry matched to the specific lot, not by how the powder dissolves. Titan supplies its lyophilized vials with lot-matched, in-house release documentation (HPLC purity against a ≥99% internal target plus ESI-MS identity) available on request. No third-party certificate is claimed — the honest edge is a real, lot-matched in-house release sheet.
What a real lot COA shows →The detail, in plain terms
Reconstituting a lyophilized peptide, at a glance.
A laboratory-handling summary for dissolving a freeze-dried research peptide. It covers solvent choice, the concentration calculation, the mechanical step, and storage of the resulting solution. It is a research reference only — it does not tell you how much of anything to administer, and it is not medical or dosing advice.
- What 'reconstitute' means
- Dissolving a lyophilized (freeze-dried) peptide solid back into a liquid so it can be handled and measured. Vendors ship dry because the solid is far more stable than a solution.
- Usual solvent
- Bacteriostatic Water for Injection, USP — sterile water with 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative, pH 5.7 (USP monograph; Pfizer/DailyMed). The preservative allows repeated entry of a multi-dose vial.
- Sterile Water (SWFI) vs BWFI
- SWFI has no preservative (single-use); BWFI is preserved (multi-entry). A few benzyl-alcohol-sensitive peptides are dissolved in SWFI or acetic-acid solution instead. Solvent is a per-compound choice.
- Concentration formula
- C (mg/mL) = peptide mass (mg) ÷ solvent volume (mL). Example: 5 mg vial + 2 mL solvent = 2.5 mg/mL. Adding solvent changes concentration, never the total mass in the vial.
- Technique
- Run solvent slowly down the inner glass wall onto the powder; swirl or roll gently, never shake. Shaking whips in air and drives interfacial aggregation of the peptide chains.
- Why dry is stable, solution is not
- In the lyophilized solid, low water activity/molecular mobility slows degradation; in solution, hydrolysis, deamidation, oxidation (Met/Cys/Trp/His) and aggregation resume — Manning et al., Pharm Res 2010;27:544-575.
- Storing the solution
- Refrigerate ~2–8°C, keep dark, avoid repeated freeze-thaw. Preserved multi-dose vials carry a USP <797> 28-day beyond-use convention. The sealed dry vial remains the most stable state.
- Identity caveat
- A clean reconstitution does not prove the vial is the right peptide — a truncated sequence dissolves just as clearly. Identity is confirmed by lot-matched mass spec, not by appearance. Titan: in-house HPLC + ESI-MS release sheet on request.
Questions researchers ask
Before you order.
- What do you use to reconstitute a research peptide?
- In most cases, bacteriostatic water — Bacteriostatic Water for Injection, USP, which is sterile water containing 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative (USP monograph; Pfizer/DailyMed labeling). The benzyl alcohol is what lets a multiple-dose vial be entered repeatedly without the solvent growing bacteria. Plain Sterile Water for Injection (SWFI) has no preservative and is single-use, and a few benzyl-alcohol-sensitive peptides are dissolved in SWFI or an acetic-acid solution instead. This is laboratory-handling information for a research reagent, not medical advice.
- How do I calculate peptide concentration after reconstitution?
- Divide the mass of peptide in the vial by the volume of solvent you add: concentration (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). A 5 mg vial reconstituted in 2 mL of bacteriostatic water gives 2.5 mg/mL; the same vial in 1 mL gives 5 mg/mL; in 5 mL, 1 mg/mL. Adding more solvent never changes how much peptide is in the vial — it only makes a more dilute, easier-to-measure solution. This is arithmetic about a laboratory solution, not a dosing instruction.
- Why shouldn't you shake a peptide vial when reconstituting?
- Because peptides can denature and aggregate at an air-liquid interface. Vigorous shaking whips air into the solution and drives exactly that kind of physical aggregation, which is one of the degradation pathways documented in the protein-stability literature (Manning et al., Pharm Res 2010;27:544-575). The gentle method — run the solvent down the inside wall of the vial onto the powder, then swirl or gently roll until dissolved — avoids that stress. Most research peptides dissolve within a few minutes at room temperature without heat.
- How long does a reconstituted peptide last, and how is it stored?
- Reconstituted (in-solution) material is far less stable than the sealed lyophilized vial, because dissolving it restarts hydrolysis, deamidation, oxidation and aggregation that are nearly frozen out in the dry solid (Manning et al., Pharm Res 2010;27:544-575). Standard laboratory handling is refrigeration at roughly 2–8°C, protection from light, and avoiding repeated freeze-thaw cycles. For preserved multi-dose vials, USP <797> uses a 28-day beyond-use convention. The practical takeaway is to reconstitute only what you will use and keep the rest sealed and dry.
- Does a clean reconstitution mean the peptide is real?
- No. A truncated, mis-synthesized, or wrong peptide can dissolve into a perfectly clear, particulate-free solution, so how nicely a vial reconstitutes tells you nothing about whether it is the correct material. Identity is established upstream by mass spectrometry matched to the specific production lot, alongside an HPLC purity figure. Titan provides lyophilized vials with lot-matched, in-house release documentation (HPLC vs a ≥99% internal target plus ESI-MS identity) on request. We do not claim a third-party certificate; the verifiable edge is a real, lot-matched in-house release sheet.